Pharmaceutical industry
An Internet pharmacy, Canadadrugmart.com, has sold 400 doses of flu vaccine to a California doctor, raising questions about the enforcement of U.S. drug regulations. The shipment, which included unlicensed foreign-made vaccine, was initially delayed by U.S. Customs but was eventually allowed to continue its journey. This incident
Pharmaceutical industry
Bristol-Myers Squibb and Medarex, Inc. have announced a worldwide collaboration to develop and commercialize a new cancer treatment, MDX-010, a fully human antibody targeting the CTLA-4 receptor. This investigational product is currently in Phase III clinical development for the treatment of metastatic melanoma, a disease that affects over 160,000
Pharmaceutical industry
NPR's Michele Norris reported on Congressional investigators seeking to uncover whether the Food and Drug Administration (FDA) has taken adequate measures to ensure the safety of children taking antidepressant drugs. Members of Congress are questioning the agency's decision to delay releasing studies that raise doubts about
Pharmaceutical industry
As prescription drug prices continue to rise, many Americans have turned to online pharmacies abroad for cheaper alternatives. However, a recent warning from the Food and Drug Administration (FDA) has raised concerns about the safety and authenticity of these imported drugs. The FDA has found problems with prescription drugs bought
Pharmaceutical industry
The FDA advisory committee voted to recommend "black box" warnings on antidepressant prescription labels, warning physicians and patients of the increased risk of suicidal thoughts in children and teenagers. The committee also agreed that pharmaceutical manufacturers should provide patient guides to the drugs' packaging describing the risks
Pharmaceutical industry
The Food and Drug Administration has acknowledged for the first time that antidepressants can increase the risk of child and adolescent suicide, sparking a heated debate on the safety of these medications. The agency's acknowledgment comes after a thorough investigation and public hearing, during which top officials revealed
Pharmaceutical industry
A joint hearing on Capitol Hill exposed the influence of the pharmaceutical industry on scientific information regarding antidepressant drugs prescribed to children. Lawmakers criticized the industry for controlling information about its products and the FDA for being passive in regulating these practices. The use of antidepressants in children is widespread,
Pharmaceutical industry
A House committee hearing into the effects of antidepressants on children took a contentious turn on Thursday, as the chairman accused the Food and Drug Administration of withholding documents. Representative Joe L. Barton, Republican of Texas, cited a leaked email instructing officials not to release the documents, which he claimed
Pharmaceutical industry
Barr Pharmaceuticals, Inc., a holding company that operates through its principal subsidiaries, Barr Laboratories, Inc. and Duramed Pharmaceuticals, Inc., has entered into an agreement with Cephalon, Inc. that provides the company with a license to manufacture and market a generic version of Cephalon's ACTIQ(R) (oral transmucosal fentanyl
Pharmaceutical industry
Cephalon, Inc., a multinational biopharmaceutical company, has announced the completion of its acquisition of CIMA LABS INC. (CIMA), a company specializing in orally disintegrating drug delivery systems. The transaction, cleared by the U.S. Federal Trade Commission (FTC), is expected to close within the next few days. Steven Ratoff, Chairman
Pharmaceutical industry
Strategic alliances between the pharmaceutical industry and biotechnology sector are set to drive revenue growth in the breast cancer therapeutic market. These partnerships are producing novel, targeted biologics that promise an advance over existing chemotherapy and hormonal treatments. Analysts at Frost & Sullivan predict that a strong pipeline of pioneering
Pharmaceutical industry
Vytorin, a cholesterol-lowering medication developed by Merck & Co and Schering-Plough, has been approved by the US FDA for the treatment of low-density lipoprotein cholesterol in patients with primary hypercholesterolemia or mixed hyperlipidemia. This medication combines the blockbuster Zocor (simvastatin) and Zetia (ezetimibe) in a dual-action approach, inhibiting both cholesterol
